OncoSil Medical Ltd (AU:OSL) has released an update.
OncoSil Medical Ltd has announced its 2024 Annual General Meeting, scheduled for November 20th at 4 PM in Melbourne, urging shareholders to participate as their votes are crucial. The company offers multiple convenient ways for shareholders to cast their proxy votes, emphasizing the importance of engaging in the decision-making process. This meeting presents a key opportunity for investors to influence OncoSil’s future strategies and growth.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.